Skip to main content
. 2022 Apr 21;14(5):905. doi: 10.3390/pharmaceutics14050905

Figure 14.

Figure 14

Western blotting for detection of myeloperoxidase (MPO) and NF-κB in: A, control group; B, untreated viral infected group; C, group treated with MH-loaded formulation F9; and D, group treated with pure MH suspension.